NEW YORK (GenomeWeb) – NanoCellect Biomedical, a developer of microfluidic cell sorting technologies, announced today that it has completed a $10 million Series B financing round, including convertible notes.

The financing included the participation of existing investors FusionX Ventures and Agilent Technologies, in addition to new investors Illumina Ventures, Anzu Partners, Vertical Venture Partners, and 5 Prime Ventures.    

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.